Latest Insider Transactions at Molina Healthcare, Inc. (MOH)
This section provides a real-time view of insider transactions for Molina Healthcare, Inc. (MOH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MOLINA HEALTHCARE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MOLINA HEALTHCARE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2021
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.74%
|
$795,000
$265.04 P/Share
|
|
May 13
2021
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
1,000
-4.67%
|
$264,000
$264.0 P/Share
|
|
May 12
2021
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
1,250
-6.77%
|
$326,250
$261.05 P/Share
|
|
May 07
2021
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
300
-1.6%
|
$78,600
$262.97 P/Share
|
|
Apr 01
2021
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
234
+5.12%
|
$54,990
$235.48 P/Share
|
|
Apr 01
2021
|
Garrey Carruthers Director |
BUY
Grant, award, or other acquisition
|
Indirect |
92
+1.72%
|
$21,620
$235.48 P/Share
|
|
Apr 01
2021
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
234
+1.62%
|
$54,990
$235.48 P/Share
|
|
Apr 01
2021
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
234
+1.08%
|
$54,990
$235.48 P/Share
|
|
Apr 01
2021
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
234
+3.54%
|
$54,990
$235.48 P/Share
|
|
Apr 01
2021
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
234
+7.1%
|
$54,990
$235.48 P/Share
|
|
Apr 01
2021
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
234
+6.0%
|
$54,990
$235.48 P/Share
|
|
Apr 01
2021
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
234
+1.23%
|
$54,990
$235.48 P/Share
|
|
Apr 01
2021
|
Marc Russo EVP, Health Plans |
SELL
Payment of exercise price or tax liability
|
Direct |
1,864
-10.27%
|
$438,040
$235.48 P/Share
|
|
Mar 01
2021
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,654
-11.56%
|
$4,363,188
$222.24 P/Share
|
|
Mar 01
2021
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,542
+13.49%
|
$6,558,324
$222.24 P/Share
|
|
Mar 01
2021
|
Marc Russo EVP, Health Plans |
BUY
Grant, award, or other acquisition
|
Direct |
4,050
+18.24%
|
$899,100
$222.24 P/Share
|
|
Mar 01
2021
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,361
-7.75%
|
$1,856,142
$222.24 P/Share
|
|
Mar 01
2021
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,610
+14.49%
|
$4,131,420
$222.24 P/Share
|
|
Mar 01
2021
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
930
-8.75%
|
$206,460
$222.24 P/Share
|
|
Mar 01
2021
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,926
+21.97%
|
$649,572
$222.24 P/Share
|
|
Mar 01
2021
|
Thomas L Tran |
SELL
Payment of exercise price or tax liability
|
Direct |
11,938
-15.74%
|
$2,650,236
$222.24 P/Share
|
|
Mar 01
2021
|
Thomas L Tran |
BUY
Grant, award, or other acquisition
|
Direct |
28,474
+38.89%
|
$6,321,228
$222.24 P/Share
|
|
Mar 01
2021
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
110,141
-23.71%
|
$24,451,302
$222.24 P/Share
|
|
Mar 01
2021
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
193,942
+26.56%
|
$43,055,124
$222.24 P/Share
|
|
Mar 01
2021
|
Garrey Carruthers Director |
SELL
Open market or private sale
|
Indirect |
825
-13.75%
|
$183,150
$222.5 P/Share
|
|
Mar 01
2021
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,039
-16.27%
|
$1,784,658
$222.24 P/Share
|
|
Mar 01
2021
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,820
+27.49%
|
$4,178,040
$222.24 P/Share
|
|
Feb 22
2021
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
375
-1.98%
|
$82,125
$219.44 P/Share
|
|
Jan 10
2021
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
889
-3.38%
|
$216,027
$243.1 P/Share
|
|
Jan 01
2021
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+4.05%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
259
+1.35%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
259
+5.94%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Garrey Carruthers Director |
BUY
Grant, award, or other acquisition
|
Indirect |
259
+4.14%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+1.82%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+7.02%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
259
+1.21%
|
$54,908
$212.68 P/Share
|
|
Jan 01
2021
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+8.39%
|
$54,908
$212.68 P/Share
|
|
Nov 09
2020
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
375
-1.97%
|
$83,250
$222.85 P/Share
|
|
Nov 06
2020
|
Garrey Carruthers Director |
SELL
Open market or private sale
|
Indirect |
925
-13.88%
|
$200,725
$217.19 P/Share
|
|
Nov 04
2020
|
Daniel Cooperman Director |
SELL
Open market or private sale
|
Direct |
3,243
-50.57%
|
$703,731
$217.5 P/Share
|
|
Nov 04
2020
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
1,500
-6.69%
|
$327,000
$218.59 P/Share
|
|
Nov 04
2020
|
Richard M Schapiro Director |
SELL
Bona fide gift
|
Direct |
250
-1.79%
|
-
|
|
Nov 04
2020
|
Richard M Schapiro Director |
SELL
Open market or private sale
|
Direct |
1,500
-9.69%
|
$325,500
$217.73 P/Share
|
|
Nov 04
2020
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
800
-4.04%
|
$173,600
$217.8 P/Share
|
|
Oct 01
2020
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
88
-2.73%
|
$16,544
$188.18 P/Share
|
|
Oct 01
2020
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
292
+4.73%
|
$54,896
$188.18 P/Share
|
|
Oct 01
2020
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
292
+7.07%
|
$54,896
$188.18 P/Share
|
|
Oct 01
2020
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
292
+1.85%
|
$54,896
$188.18 P/Share
|
|
Oct 01
2020
|
Garrey Carruthers Director |
BUY
Grant, award, or other acquisition
|
Indirect |
292
+4.2%
|
$54,896
$188.18 P/Share
|
|
Oct 01
2020
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
292
+1.45%
|
$54,896
$188.18 P/Share
|